Treatment Protocol for the Use of Sorafenib in Patients With Advanced Renal Cell Carcinoma

NCT00111020 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

2567

Enrollment

INDUSTRY

Sponsor class

Conditions

Carcinoma, Renal Cell

Interventions

DRUG: Sorafenib (Nexavar, BAY43-9006)

Sponsor

Bayer